Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review

ACTA MEDICA INDONESIANA · Vol. 49 No. 4 (2018)

ISSN
2338-2732, 0125-9326
Terbit
2018-01-19
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: treatment guidelines for ulcerative colitis (UC) not yet established. Currently, mesalazine, corticosteroids, and immunomodulators are treatment options for UC. However, they are known to have unpleaseant side effects such as nausea, vomiting, headaches, hepatitis, and male infertility. Curcumin is found in Turmeric plants (Curcuma longa L.), which possesses both anti-inflammatory and antioxidant properties. This study aimed to determine whether curcumin as adjuvant therapy can induce or maintain remission in UC patients. Methods: structured search in three database (Cochrane, PubMed, Proquest) using “Curcumin”, “remission” and “Ulcerative Colitis” as keywords. Inclusion criteria is randomized controlled trials (RCTs), meta-analysis, or systematic review using curcumin as adjuvant therapy in adult UC patients.Results: we found 49 articles. After exclusion, three RCTs were reviewed; two examined curcumin efficacy to induce remission and one for remision maintenance in UC. Curcumin was significantly more effective than placebo in all RCTs. The efficacy of curcumin could be explained by its anti-inflammatory properties, which inhibit NF-kB pathway. Regulation of oxidant/anti-oxidant balance can modify the release of cytokines. However, methods varied between RCTs. Therefore, they cannot be compared objectively. Futhermore, the sample size were small (n= 50, 45, 89) therefore the statistical power was not enough to generate representative results in all UC patients.Conclusion: Available evidence showed that curcumin has the potential to induce and maintain remission in UC patients with no serious side effects. However, further studies with larger sample size are needed to recommend it as adjuvant therapy of ulcerative colitis.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 192 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Murdani AbdullahAfiliasi tidak diketahui4
Dadang MakmunAfiliasi tidak diketahui3
Kaka RenaldiAfiliasi tidak diketahui3
Juferdy KurniawanAfiliasi tidak diketahui2
Ari F SyamAfiliasi tidak diketahui2
Randy AdiwinataAfiliasi tidak diketahui2
Achmad FauziAfiliasi tidak diketahui2
Hasan MaulahelaAfiliasi tidak diketahui2
Rabbinu Rangga PribadiAfiliasi tidak diketahui2
Saskia Aziza NursyirwanAfiliasi tidak diketahui2
Irsan HasanAfiliasi tidak diketahui1
Rino Alvani GaniAfiliasi tidak diketahui1
Dewi FriskaAfiliasi tidak diketahui1
Deriyan Sukma WidjajaAfiliasi tidak diketahui1
Liana SrisawitriAfiliasi tidak diketahui1
Siti SetiatiAfiliasi tidak diketahui1
Laura A SiahaanAfiliasi tidak diketahui1
Dyah PurnamasariAfiliasi tidak diketahui1
Laras BudiyaniAfiliasi tidak diketahui1
Amanda P UtariAfiliasi tidak diketahui1
Ari Fahrial SyamAfiliasi tidak diketahui1
Muhammad Begawan BestariAfiliasi tidak diketahui1
Roy SutiknoAfiliasi tidak diketahui1
Kresna Dharma SuryanaAfiliasi tidak diketahui1
Andrea LivinaAfiliasi tidak diketahui1
Bradley Jimmy WalelengAfiliasi tidak diketahui1
Fandy GosalAfiliasi tidak diketahui1
Luciana RottyAfiliasi tidak diketahui1
Jeanne WinartaAfiliasi tidak diketahui1
Andrew WalelengAfiliasi tidak diketahui1
Harlinda HaroenAfiliasi tidak diketahui1
Linda RottyAfiliasi tidak diketahui1
Cecilia hendrattaAfiliasi tidak diketahui1
Pearla LasutAfiliasi tidak diketahui1
Angelica AbigaelAfiliasi tidak diketahui1
Lidya TanjayaAfiliasi tidak diketahui1
Andri Sanityoso SulaimanAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients:  an Evidence-based Clinical Review</dc:title>
	<dc:creator>Simadibrata, Marcellus</dc:creator>
	<dc:creator>Halimkesuma, Christopher Christian</dc:creator>
	<dc:creator>Suwita, Benedicta Mutiara</dc:creator>
	<dc:subject xml:lang="en-US">curcumin</dc:subject>
	<dc:subject xml:lang="en-US">remission</dc:subject>
	<dc:subject xml:lang="en-US">maintenance</dc:subject>
	<dc:subject xml:lang="en-US">ulcerative colitis</dc:subject>
	<dc:subject xml:lang="en-US">gastroenterology</dc:subject>
	<dc:description xml:lang="en-US">Background: treatment guidelines for ulcerative colitis (UC) not yet established. Currently, mesalazine, corticosteroids, and immunomodulators are treatment options for UC. However, they are known to have unpleaseant side effects such as nausea, vomiting, headaches, hepatitis, and male infertility. Curcumin is found in Turmeric plants (Curcuma longa L.), which possesses both anti-inflammatory and antioxidant properties. This study aimed to determine whether curcumin as adjuvant therapy can induce or maintain remission in UC patients. Methods: structured search in three database (Cochrane, PubMed, Proquest) using “Curcumin”, “remission” and “Ulcerative Colitis” as keywords. Inclusion criteria is randomized controlled trials (RCTs), meta-analysis, or systematic review using curcumin as adjuvant therapy in adult UC patients.Results: we found 49 articles. After exclusion, three RCTs were reviewed; two examined curcumin efficacy to induce remission and one for remision maintenance in UC. Curcumin was significantly more effective than placebo in all RCTs. The efficacy of curcumin could be explained by its anti-inflammatory properties, which inhibit NF-kB pathway. Regulation of oxidant/anti-oxidant balance can modify the release of cytokines. However, methods varied between RCTs. Therefore, they cannot be compared objectively. Futhermore, the sample size were small (n= 50, 45, 89) therefore the statistical power was not enough to generate representative results in all UC patients.Conclusion: Available evidence showed that curcumin has the potential to induce and maintain remission in UC patients with no serious side effects. However, further studies with larger sample size are needed to recommend it as adjuvant therapy of ulcerative colitis.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2018-01-19</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/520</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 49 No. 4 (2017): Acta Medica Indonesiana; 363</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/520/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>